Jefferies Group's BMRN Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 468,146 shares of BioMarin Pharmaceutical Inc. (BMRN) worth $26.45 M, representing 0.18% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in BMRN, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 467,018 shares. Largest reduction occurred in Q2 2023, reducing 22,904 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's BioMarin Pharmaceutical (BMRN) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioMarin Pharmaceutical (BMRN) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1,128 | Add 0.24% | 468,146 | $56.49 |
| Q4 2025 | +467,018 | New Buy | 467,018 | $59.43 |
| Q2 2025 | -6,169 | Sold Out | 0 | $0.00 |
| Q1 2025 | +6,169 | New Buy | 6,169 | $70.69 |
| Q4 2024 | -4,350 | Sold Out | 0 | $0.00 |
| Q3 2024 | +4,350 | New Buy | 4,350 | $70.29 |
| Q2 2024 | -10,600 | Sold Out | 0 | $0.00 |
| Q1 2024 | +379 | Add 3.71% | 10,600 | $87.34 |
| Q4 2023 | +7,231 | Add 241.84% | 10,221 | $96.42 |
| Q3 2023 | -2,023 | Reduce 40.36% | 2,990 | $88.48 |
| Q2 2023 | -22,904 | Reduce 82.04% | 5,013 | $86.68 |
| Q1 2023 | -17,855 | Reduce 39.01% | 27,917 | $97.24 |
| Q4 2022 | +45,772 | New Buy | 45,772 | $103.49 |
Jefferies Group's BioMarin Pharmaceutical Investment FAQs
Jefferies Group first purchased BioMarin Pharmaceutical Inc. (BMRN) in Q4 2022, acquiring 45,772 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held BioMarin Pharmaceutical Inc. (BMRN) for 13 quarters since Q4 2022.
Jefferies Group's largest addition to BioMarin Pharmaceutical Inc. (BMRN) was in Q4 2025, adding 467,018 shares worth $27.75 M.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 468,146 shares of BioMarin Pharmaceutical Inc. (BMRN), valued at approximately $26.45 M.
As of the Q1 2026 filing, BioMarin Pharmaceutical Inc. (BMRN) represents approximately 0.18% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in BioMarin Pharmaceutical Inc. (BMRN) was 468,146 shares, as reported at the end of Q1 2026.